Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability

Z. Tong, G. R. Pitts, Seungkwon You, D. N. Foster, M. E. El Halawani

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This study evaluates the transcriptional and post-transcriptional regulation of prolactin (PRL) by vasoactive intestinal peptide (VIP). Pituitary nuclei from laying (control), incubating (with enhanced VIP secretion), and VIP-immunized laying turkey hens, and from pituitary cells cultured with or without VIP were used in nuclear run-on transcription assays. Cytoplasmic PRL mRNA was analyzed by slot blot hybridization. PRL transcription was greater in hyperprolactinemic incubating birds (PRL/β- actin=3.33) than in laying birds (PRL/β-actin=1.83). VIP-immunoneutralized birds had 47% and 51% decreases in PRL transcription and cytoplasmic PRL mRNA, respectively when compared with laying birds. In primary pituitary cell cultures, VIP significantly increased the transcription rate of PRL (3.8- fold) and cytoplasmic PRL mRNA (3.2-fold) compared with that of non-VIP- treated pituitary cells. The stability of pre-existing PRL mRNA was measured by Northern blot analysis after addition of actinomycin D. PRL mRNA half, lives were calculated using a two-component model, with a first-long component of 18.0 ± 1.0 h and a second-short component of 3.7 ± 0.7 h in non-VIP-treated pituitary cells. Both half-lives were significantly increased (53.2 ± 6.9 and 26.3 ± 4.3 h) in VIP-treated cells. The present data show that VIP acts to stimulate PRL expression by up-regulating the transcription rate of PRL and by enhancing PRL mRNA stability.

Original languageEnglish
Pages (from-to)259-266
Number of pages8
JournalJournal of Molecular Endocrinology
Volume21
Issue number3
DOIs
Publication statusPublished - 1998 Dec 1
Externally publishedYes

Fingerprint

Vasoactive Intestinal Peptide
RNA Stability
Prolactin
Gene Expression
Birds
Messenger RNA
Actins
Intestinal Secretions
Peptides
Primary Cell Culture
Dactinomycin
Northern Blotting
Cultured Cells

ASJC Scopus subject areas

  • Endocrinology

Cite this

Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability. / Tong, Z.; Pitts, G. R.; You, Seungkwon; Foster, D. N.; El Halawani, M. E.

In: Journal of Molecular Endocrinology, Vol. 21, No. 3, 01.12.1998, p. 259-266.

Research output: Contribution to journalArticle

@article{1176dc67dd8f40178319ec3b435de71b,
title = "Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability",
abstract = "This study evaluates the transcriptional and post-transcriptional regulation of prolactin (PRL) by vasoactive intestinal peptide (VIP). Pituitary nuclei from laying (control), incubating (with enhanced VIP secretion), and VIP-immunized laying turkey hens, and from pituitary cells cultured with or without VIP were used in nuclear run-on transcription assays. Cytoplasmic PRL mRNA was analyzed by slot blot hybridization. PRL transcription was greater in hyperprolactinemic incubating birds (PRL/β- actin=3.33) than in laying birds (PRL/β-actin=1.83). VIP-immunoneutralized birds had 47{\%} and 51{\%} decreases in PRL transcription and cytoplasmic PRL mRNA, respectively when compared with laying birds. In primary pituitary cell cultures, VIP significantly increased the transcription rate of PRL (3.8- fold) and cytoplasmic PRL mRNA (3.2-fold) compared with that of non-VIP- treated pituitary cells. The stability of pre-existing PRL mRNA was measured by Northern blot analysis after addition of actinomycin D. PRL mRNA half, lives were calculated using a two-component model, with a first-long component of 18.0 ± 1.0 h and a second-short component of 3.7 ± 0.7 h in non-VIP-treated pituitary cells. Both half-lives were significantly increased (53.2 ± 6.9 and 26.3 ± 4.3 h) in VIP-treated cells. The present data show that VIP acts to stimulate PRL expression by up-regulating the transcription rate of PRL and by enhancing PRL mRNA stability.",
author = "Z. Tong and Pitts, {G. R.} and Seungkwon You and Foster, {D. N.} and {El Halawani}, {M. E.}",
year = "1998",
month = "12",
day = "1",
doi = "10.1677/jme.0.0210259",
language = "English",
volume = "21",
pages = "259--266",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "3",

}

TY - JOUR

T1 - Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability

AU - Tong, Z.

AU - Pitts, G. R.

AU - You, Seungkwon

AU - Foster, D. N.

AU - El Halawani, M. E.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - This study evaluates the transcriptional and post-transcriptional regulation of prolactin (PRL) by vasoactive intestinal peptide (VIP). Pituitary nuclei from laying (control), incubating (with enhanced VIP secretion), and VIP-immunized laying turkey hens, and from pituitary cells cultured with or without VIP were used in nuclear run-on transcription assays. Cytoplasmic PRL mRNA was analyzed by slot blot hybridization. PRL transcription was greater in hyperprolactinemic incubating birds (PRL/β- actin=3.33) than in laying birds (PRL/β-actin=1.83). VIP-immunoneutralized birds had 47% and 51% decreases in PRL transcription and cytoplasmic PRL mRNA, respectively when compared with laying birds. In primary pituitary cell cultures, VIP significantly increased the transcription rate of PRL (3.8- fold) and cytoplasmic PRL mRNA (3.2-fold) compared with that of non-VIP- treated pituitary cells. The stability of pre-existing PRL mRNA was measured by Northern blot analysis after addition of actinomycin D. PRL mRNA half, lives were calculated using a two-component model, with a first-long component of 18.0 ± 1.0 h and a second-short component of 3.7 ± 0.7 h in non-VIP-treated pituitary cells. Both half-lives were significantly increased (53.2 ± 6.9 and 26.3 ± 4.3 h) in VIP-treated cells. The present data show that VIP acts to stimulate PRL expression by up-regulating the transcription rate of PRL and by enhancing PRL mRNA stability.

AB - This study evaluates the transcriptional and post-transcriptional regulation of prolactin (PRL) by vasoactive intestinal peptide (VIP). Pituitary nuclei from laying (control), incubating (with enhanced VIP secretion), and VIP-immunized laying turkey hens, and from pituitary cells cultured with or without VIP were used in nuclear run-on transcription assays. Cytoplasmic PRL mRNA was analyzed by slot blot hybridization. PRL transcription was greater in hyperprolactinemic incubating birds (PRL/β- actin=3.33) than in laying birds (PRL/β-actin=1.83). VIP-immunoneutralized birds had 47% and 51% decreases in PRL transcription and cytoplasmic PRL mRNA, respectively when compared with laying birds. In primary pituitary cell cultures, VIP significantly increased the transcription rate of PRL (3.8- fold) and cytoplasmic PRL mRNA (3.2-fold) compared with that of non-VIP- treated pituitary cells. The stability of pre-existing PRL mRNA was measured by Northern blot analysis after addition of actinomycin D. PRL mRNA half, lives were calculated using a two-component model, with a first-long component of 18.0 ± 1.0 h and a second-short component of 3.7 ± 0.7 h in non-VIP-treated pituitary cells. Both half-lives were significantly increased (53.2 ± 6.9 and 26.3 ± 4.3 h) in VIP-treated cells. The present data show that VIP acts to stimulate PRL expression by up-regulating the transcription rate of PRL and by enhancing PRL mRNA stability.

UR - http://www.scopus.com/inward/record.url?scp=0032413978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032413978&partnerID=8YFLogxK

U2 - 10.1677/jme.0.0210259

DO - 10.1677/jme.0.0210259

M3 - Article

C2 - 9845667

AN - SCOPUS:0032413978

VL - 21

SP - 259

EP - 266

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 3

ER -